Bayer subsidiary BlueRock Therapeutics has signed with Rune Labs to use the neurology software and data platform company’s clinical trial tech to get a sharper picture of Parkinson’s disease patient activity and encourage better engagement in its cell therapy study.
Bayer subsidiary BlueRock taps Rune Labs ... - Cure Parkinson's
Bayer subsidiary BlueRock taps Rune Labs for Parkinson's study software
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Not true..."The agreement marks the first operational use of Rune’s StriveStudy platform, with the aim of providing real-world, continuous capture of Parkinson's symptom data, the company said in a March 14 press release" My wife has had the Rune Labs watch and program for about 4mos. They sent it to her after the DBS surgery.
Not what you're looking for?
You may also like...
First Red light therapy in Parkinsons study to be published by Australian researchers
one of the Australian researchers involved in the study about to be published. Sounds positive....
Study finds overabundance of opportunistic pathogens in the guts of persons with Parkinson's
I'm wondering if this study shows any benefit to taking probiotics or any bacteria strains in...
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study 2022...
BlueRock the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy
com/business/healthcare-pharmaceuticals/bayer-phase-i-trial-results-parkinsons-cell-therapy-positive
Related Posts
Study: Compound in fruit, herbs may prevent, reverse Parkinson's brain damage
Another Study Finds A Link Between Covid-19 and Parkinson's Disease 
Free Webinar: “Zhittya's Parkinson's Disease Research Study: 6-Month Patient Follow-Up Report”
small study, but researchers report evidence of picornavirus antigen in 7 of 9 Parkinsons postmortem samples of midbrain- The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study
